SLSimulations Plus, Inc. SLP · NASDAQ
$18.50 +0.00% (+$0.00)
- Market cap
- $374.2M
- Enterprise value
- $339.3M
- P/E
- 46.2x
- Forward P/E
- 20.5x
- PEG
- -
- P/S
- 4.6x
- P/FCF
- 14.3x
- EV/EBITDA
- 25.9x
- ROIC
- 5.3%
- Gross margin
- 63.4%
- Net margin
- 9.9%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -2.7x
- Beta
- 1.32
- Free float
- 83.1%
About the company
Simulations Plus is an American company focused on the development and provision of software solutions in the pharmaceutical and biotechnology research field. The company's main headquarters is located in Lancaster, California. Simulations Plus specializes in developing models and simulations for pharmacokinetics, pharmacodynamics, and other aspects of drug research.
Sector
Technology
Industry
Software - Application
CEO
Shawn O'Connor
Employees
213
Headquarters
Research Triangle Park
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 32 USD is left as free cash.
- What to watch: It earns only 5.3 USD a year on every 100 USD of invested capital.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $35.3M against $487.0K.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number